Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

PURPOSE: To estimate associations between use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) and breast cancer recurrence in a large Danish cohort. PATIENTS AND METHODS: We enrolled 18,733 women diagnosed with nonmetastatic breast cancer betwee...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sørensen, Gitte Vrelits, Ganz, Patricia A., Cole, Steven W., Pedersen, Lars A., Toft Sørensen, Henrik, Cronin-Fenton, Deirdre P., Peter Garne, Jens, Christiansen, Peer M., Lash, Timothy L., Ahern, Thomas P.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2013
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3677839/
https://ncbi.nlm.nih.gov/pubmed/23650417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.43.9190
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados